KD Logo

Investing in Amicus Therapeutics Inc (FOLD): What You Must Know

In a filing, Amicus Therapeutics Inc revealed its President and CEO Campbell Bradley L unloaded Company’s shares for reported $75524.0 on May 01 ’24. In the deal valued at $10.07 per share,7,500 shares were sold. As a result of this transaction, Campbell Bradley L now holds 886,654 shares worth roughly $8.02 million.

Then, Campbell Bradley L sold 7,500 shares, generating $87,496 in total proceeds. Upon selling the shares at $11.67, the President and CEO now owns 886,654 shares.

Before that, MCGLYNN MARGARET G sold 7,500 shares. Amicus Therapeutics Inc shares valued at $100,500 were divested by the Director at a price of $13.40 per share. As a result of the transaction, MCGLYNN MARGARET G now holds 59,289 shares, worth roughly $0.54 million.

Morgan Stanley upgraded its Amicus Therapeutics Inc [FOLD] rating to an Overweight from a an Equal-weight in a research note published on December 19, 2023; the price target was increased to $20 from $15. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who began to cover the stock in early September with a ‘”an Equal-weight”‘ rating. SVB Leerink revised its rating on January 14, 2022. It rated FOLD as “an Outperform” which previously was an “a Mkt perform”.

Price Performance Review of FOLD

On Monday, Amicus Therapeutics Inc [NASDAQ:FOLD] saw its stock fall -2.06% to $9.04. Over the last five days, the stock has lost -12.57%. Amicus Therapeutics Inc shares have fallen nearly -36.29% since the year began. Nevertheless, the stocks have fallen -22.60% over the past one year. While a 52-week high of $14.57 was reached on 01/02/24, a 52-week low of $9.13 was recorded on 05/13/24. SMA at 50 days reached $11.15, while 200 days put it at $12.02. A total of 2.76 million shares were traded, compared to the trading of 3.52 million shares in the previous session.

Levels Of Support And Resistance For FOLD Stock

The 24-hour chart illustrates a support level at 8.89, which if violated will result in even more drops to 8.74. On the upside, there is a resistance level at 9.32. A further resistance level may holdings at 9.60. The Relative Strength Index (RSI) on the 14-day chart is 24.27, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.83, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.87%. Stochastics %K at 6.96% indicates the stock is a buying.

Most Popular

[the_ad id="945"]